26 /100
MEDIUM RISK
Score updated Jul 14, 2026

ASPN — Aspen Aerogels, Inc. Dilution Risk Tracker

Track ASPN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ASPN — Get alerts when the score changes →

As of July 14, 2026, Aspen Aerogels, Inc. (ASPN) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Aspen Aerogels, Inc. has a market capitalization of $530.42M, 82.88M shares outstanding, 170 institutional holders tracked. Key dilution vectors include approximately 807 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
🔁 Convertible Conversion 40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
🔔 Track ASPN — Get forecast alerts →

💹 Market Data

Market Cap$530.42M
Shares Outstanding82.88M
Float76.72M
Cash$176.37M
Debt$26.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.7% shares (2026Q1 vs prior)
170 institutional holders · 77.01M shares
#1 KIM, LLC 12.28M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 6.87M shares
#3 OAKTOP CAPITAL MANAGEMENT II, L.P. 5.17M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.10M
Days to Cover3.8
% of Float9.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2014
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ASPN Shareholders

Aspen Aerogels, Inc. (ASPN) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for ASPN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ASPN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ASPN alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ASPN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ASPN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ASPN
📊 ASPN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ASPN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.